英国医院眼科服务中高眼压向视野缺损的进展
该研究回顾性分析英格兰五家眼科诊所45 309例高眼压(OHT)患者电子病历,以视野缺损进展定义转化为原发性开角型青光眼(POAG)。5年累积转化风险为17.5%(95%CI 15.4%–19.6%),年龄增长增加转化风险,降眼压治疗降低转化风险。
要点
- OHT患者5年累积转化为POAG的风险为17.5%(95%CI 15.4%–19.6%)。
- 降眼压治疗与转化风险降低相关(HR 0.45,95%CI 0.35–0.57,p<0.001)。
核心结论
- 英国眼科诊所管理的OHT患者5年内不足五分之一转化为POAG,提示许多患者可能无需密集随访。
- 研究为当前管理(包括降眼压治疗)降低转化风险提供了真实世界证据。
研究设计与样本
- 回顾性分析英格兰五家区域不同的眼科诊所45 309例患者电子病历。
- 转化定义为视野恶化(连续两次检测按青光眼分期系统2评为1期或更差)。
- 采用Cox比例风险模型分析年龄、性别、治疗状态和基线眼压与转化的关联。
主要发现
- 5年累积转化为POAG的风险为17.5%(95%CI 15.4%–19.6%)。
- 年龄较大与转化风险升高相关(HR 1.35/十年,95%CI 1.22–1.50,p<0.001)。
- 降眼压治疗与转化风险降低相关(HR 0.45,95%CI 0.35–0.57,p<0.001)。
- 治疗组和未治疗组预测5年转化率分别为14.0%和26.9%。
关键数值与推荐
- 转化定义:连续两次视野检测按青光眼分期系统2评为1期或更差。
- 5年累积转化风险17.5%(95%CI 15.4%–19.6%)。
- 降眼压治疗HR 0.45(95%CI 0.35–0.57,p<0.001)。
临床怎么用
- OHT患者5年转化风险较低,可考虑对部分患者减少随访强度。
- 年龄较大者转化风险较高,可能需要更密切监测。
- 降眼压治疗与转化风险降低相关,支持当前管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are more than one million National Health Service visits in England and Wales each year for patients with glaucoma or ocular hypertension (OHT). With the ageing population and an increase in optometric testing, the economic burden of glaucoma-related visits is predicted to increase. We examined the conversion rates of OHT to primary open-angle glaucoma (POAG) in England and assessed factors associated with risk of conversion. METHODS: Electronic medical records of 45 309 patients from five regionally different glaucoma clinics in England were retrospectively examined. Conversion to POAG from OHT was defined by deterioration in visual field (two consecutive tests classified as stage 1 or worse as per the glaucoma staging system 2). Cox proportional hazards models were used to examine factors (age, sex, treatment status and baseline intraocular pressure (IOP)) associated with conversion. RESULTS: The cumulative risk of conversion to POAG was 17.5% (95% CI 15.4% to 19.6%) at 5 years. Older age (HR 1.35 per decade, 95% CI 1.22 to 1.50, p<0.001) was associated with a higher risk of conversion. IOP-lowering therapy (HR 0.45, 95% CI 0.35 to 0.57, p<0.001) was associated with a lower risk of conversion. Predicted 5-year conversion rates for treated and untreated groups were 14.0% and 26.9%, respectively. CONCLUSION: Less than one-fifth of OHT patients managed in glaucoma clinics in the UK converted to POAG over a 5-year period, suggesting many patients may require less intensive follow-up. Our study provides real-world evidence for the efficacy of current management (including IOP-lowering treatment) at reducing risk of conversion.
引用
- Kelly SR, Khawaja AP, Bryan SR, et al. Progression from ocular hypertension to visual field loss in the English hospital eye service. Br J Ophthalmol. 2020. PMID: 32217541. doi:10.1136/bjophthalmol-2019-315052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。